Contributor's Links: New York Shock Exchange

B.A. in economics and MBA from top 10 business school. I have over 10 years of M&A / corporate finance experience. Currently head the New York Shock Exchange, a youth mentorship program that teaches investment management skills and ... more


GE Shocks Investors Again
Tuesday GE announced a $6B Q4 after-tax charge related to its insurance operations. The news shocked investors. Until Power Systems is rightsized there could be more surprises on the way.
CSX Earnings Preview
CSX reports Q4 earnings after-hours. The company has embarked on an aggressive cost-cutting campaign. Cost cuts may have come at the expense of service quality.
Schlumberger Earnings Preview
SLB reports Q4 earnings Friday. It should deliver strong results with oil prices hovering around $70. It could face headwinds if the OPEC oil supply cuts do not hold up long term.
Valeant, Ackman Settle Insider Trading Lawsuit For $290 Million
Valeant and Pershing Square settled their AGN insider trading case for $290MM. The settlement saved substantial time and resources. I believe there is a potential for future AGN shareholders to sue, creating a need for more settlements.
A Moody's Downgrade Could Punish Mallinckrodt
MNK's $1.2B acquisition of SCMP will diversity its earnings stream but will likely increase debt by over $800MM. Proforma debt/EBITDA could reach 4.8x - 4.9x. Moody's put MNK's debt under review for a rating downgrade.
BlackBerry Is Betwixt And Between
BlackBerry's top line growth continues to fall. Revenue within its core software and services segments grew by double digits. At quarterly revenue of $190MM lacks the scale. The company is betwixt and between.


Latest Comments
Seadrill Kicks The Can Down The Road
3 months ago

Well said. Oil companies are in hoc to banks by the hundreds of billions. If banks take a loss then it's an act of treason. The banks have to be propped up so the oil companies also have to be propped up.

In this article: SDRL
Greenbrier: Did Railcar Orders Really Fall 70%?
1 year ago

The Shock Exchange is bearish on the economy. Revenue and earnings for cyclical names like GBX will continue to fall.

In this article: GBX
3 Reasons Weatherford Could Be The Next Enron
2 years ago

Thank you. SE

In this article: JPM, WFT
3 Reasons Weatherford Could Be The Next Enron
2 years ago

What details did Oppenheimer give? The Shock Exchange's article is extremely detailed, with spot on analysis. WFT's bonds also trade at steep discounts, implying impending bankruptcy. SE would listen to bond investors before listening to an analyst who provides "de-facto PR" for companies.

In this article: JPM, WFT
Weatherford Might Need $1.4 Billion To Avoid Bankruptcy
2 years ago

Are you asking which one of those stocks the Shock Exchange would buy? He wouldn't buy any stocks at this juncture.

In this article: WFT
Will Weatherford's Debacle Destroy The Halliburton - Baker Hughes Merger?
2 years ago

The Halliburton-Baker Hughes saga is interesting. It's hard to predict whether the merger will be approved or not. SE

In this article: WFT
BlackBerry Is Now The Software Company John Chen Envisioned
2 years ago

Susan, the Shock Exchange agrees with you. However, with more data being put on line, it makes security paramount. Major hacks or security breaches could bring BlackBerry back into favor.

In this article: BBRY
Gilead's HCV Sales May Have Peaked
2 years ago

The Shock Exchange doesn't see that way. Starts peaked in the U.S. in Q1. Starts are also beginning to decline in Europe. A combination of declining volume and declining prices could punish Gilead. The one caveat is that HCV sales are ramping up in Japan which could mask how poorly the U.S. and Europe are doing.

In this article: GILD
1 to 8 of 8 comments




Latest Posts
Did Teva Offer 'Illegal' Payments For Opioid Sales?
Teva is suspected of offering illegal payments to Canadian pharmacies to spur opioid sales. If the probe leads to regulators reducing Teva's sales to Canada it could be devastating.
Allergan Punished After Judge Invalidates Restasis Patents
Judge Bryson invalidated AGN's Restasis patents. The bottleneck for generic Restasis could be FDA approval. Generic Restasis could hurt AGN's earnings and sentiment.
Allergan: Judge Asks If Patent Transfer To Mohawks Is A 'Sham'
The judge overseeing AGN's federal patent trial questioned whether its patent deal with the Mohawks was a sham. The judge wants AGN to decide whether the Mohawks will serve as a co-defendant in the federal patent trial.
Mohawk Tribe Seeks To Dismiss Allergan Patent Case
St. Regis Mohawk Tribe seeks to dismiss MYL's challenge to AGN's Restasis patents. St. Regis claims the patent board does not have jurisdiction over it. MYL claims the AGN, St. Regis partnership is a desperate attempt to thwart generic competition.
Allergan Partners With Indian Tribe To Protect Restasis Patents
AGN enjoined St. Regis Mohawk Tribe to protect Restasis patents. It highlights how important Restasis is to AGN. Investors could focus on Restasis' decline or AGN's lack of R&D prowess. Growth is dead and so is AGN.
Cory Booker Blocks Importation Of Cheaper Drugs; Will Trump Hit Back?
Senator Cory Booker voted against Senator Bernie Sanders' plan to import cheaper drugs. President Trump also supports the importation of drugs. The fight over importing drugs would make good theater and potentially impact VRX.
Gilead Gets Its Comeuppance
GILD's Q4 revenue fell 3% Q/Q. HIV was a major disappointment, falling 4%. Management guided that 2017 revenue could fall from 18% - 25% Y/Y. HCV sales could be off 39% - 49%. GILD got it comeuppance after the stock fell about 5%.
Weatherford International: The Oil Industry's Bernie Madoff?
Bernie Madoff's $50B Ponzi scheme defined the 2008 Financial Crisis. As the market and the economy stalls, more Ponzi schemes could emerge. Like Madoff, WFT is insolvent by $3.1B and thirsty for new investors to repay current ones. Sans new money WFT could become the oil industry's Bernie Madoff.

Work Experience